Gene · 6241
Papers4,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38804044 | PubTator, text mining | PubMed |
| Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor. | Cancer Lett | 2024 | 38801884 | PubTator, text mining | PubMed |
| The Features of Shared Genes among Transcriptomes Probed in Atopic Dermatitis, Psoriasis, and Inflammatory Acne: S100A9 Selection as the Target Gene. | Protein Pept Lett | 2024 | 38766834 | PubTator, text mining | PubMed |
| Machine learning and weighted gene co-expression network analysis identify a three-gene signature to diagnose rheumatoid arthritis. | Front Immunol | 2024 | 38711508 | PubTator, text mining | PubMed |
| Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study. | Medicine (Baltimore) | 2024 | 38701255 | PubTator, text mining | PubMed |
| Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities. | Daru | 2024 | 38683491 | PubTator, text mining | PubMed |
| Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study). | Cancer | 2024 | 38682652 | PubTator, text mining | PubMed |
| Environmental Exposure to Persistent Organic Pollutants and Its Association with Endometriosis Risk: Implications in the Epithelial-Mesenchymal Transition Process. | Int J Mol Sci | 2024 | 38674005 | PubTator, text mining | PubMed |
| Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer. | Chem Biol Interact | 2024 | 38636790 | PubTator, text mining | PubMed |
| A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer. | PLoS One | 2024 | 38635758 | PubTator, text mining | PubMed |
| Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development. | Pharmgenomics Pers Med | 2024 | 38623558 | PubTator, text mining | PubMed |
Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4+ and CD8+ T cells and protects against recurrent genital herpes. | J Virol | 2024 | 38587378 | PubTator, text mining | PubMed |
| DELVE: feature selection for preserving biological trajectories in single-cell data. | Nat Commun | 2024 | 38553455 | PubTator, text mining | PubMed |
| Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics. | Comput Biol Med | 2024 | 38552279 | PubTator, text mining | PubMed |
| Characterization of Mitoribosomal Small Subunit unit genes related immune and pharmacogenomic landscapes in renal cell carcinoma. | IUBMB Life | 2024 | 38551358 | PubTator, text mining | PubMed |
| Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment. | Med Oncol | 2024 | 38526604 | PubTator, text mining | PubMed |
| GINS2 promotes the progression of human HNSCC by altering RRM2 expression. | Cancer Biomark | 2024 | 38517779 | PubTator, text mining | PubMed |
| A structure-based designed small molecule depletes hRpn13Pru and a select group of KEN box proteins. | Nat Commun | 2024 | 38509117 | PubTator, text mining | PubMed |
| Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma. | Cancers (Basel) | 2024 | 38473423 | PubTator, text mining | PubMed |
| Targeting the Cell Cycle, RRM2 and NF-κB for the Treatment of Breast Cancers. | Cancers (Basel) | 2024 | 38473336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6241/papers?page=16